Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

INTRODUCTION: Non-clear cell renal cell carcinoma (nccRCC) and sarcomatoid renal cell carcinoma (sRCC) are underrepresented in clinical trials. Treatment approaches are frequently extrapolated from data of clear cell renal cell carcinoma, in which pazopanib is non-inferior to sunitinib. We aim to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonadioa, Renata Colombo, Velho, Pedro Isaacsson, Marta, Guilherme Nader, Nardo, Mirella, Souza, Manoel Carlos LA, Muniz, David QB, Bezerra, Regis OF, Bispo, Raisa KA, Faraj, Sheila F, Bastos, Diogo A, Dzik, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946421/
https://www.ncbi.nlm.nih.gov/pubmed/31921344
http://dx.doi.org/10.3332/ecancer.2019.973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946421/
https://www.ncbi.nlm.nih.gov/pubmed/31921344
http://dx.doi.org/10.3332/ecancer.2019.973

Ejemplares similares